These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19191030)

  • 41. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
    Basarkar A; Devineni D; Palaniappan R; Singh J
    Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay of formulation and process methodology on the extent of nifedipine molecular dispersion in polymers.
    Huang J; Li Y; Wigent RJ; Malick WA; Sandhu HK; Singhal D; Shah NH
    Int J Pharm; 2011 Nov; 420(1):59-67. PubMed ID: 21871546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior.
    Karavelidis V; Karavas E; Giliopoulos D; Papadimitriou S; Bikiaris D
    Int J Nanomedicine; 2011; 6():3021-32. PubMed ID: 22162659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
    Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
    Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nano-sized flake carboxymethyl cassava starch as excipient for solid dispersions.
    Lin X; Gao W; Li C; Chen J; Yang C; Wu H
    Int J Pharm; 2012 Feb; 423(2):435-9. PubMed ID: 22197771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
    He X; Ma J; Mercado AE; Xu W; Jabbari E
    Pharm Res; 2008 Jul; 25(7):1552-62. PubMed ID: 18196205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles.
    Daman Z; Ostad S; Amini M; Gilani K
    Int J Pharm; 2014 Jul; 468(1-2):142-51. PubMed ID: 24731731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices.
    Pawar AA; Chen DR; Venkataraman C
    Int J Pharm; 2012 Jul; 430(1-2):228-37. PubMed ID: 22469694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro release of a water-soluble agent from low viscosity biodegradable, injectable oligomers.
    Sharifpoor S; Amsden B
    Eur J Pharm Biopharm; 2007 Mar; 65(3):336-45. PubMed ID: 17084069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug incorporation and release of water soluble drugs from novel functionalized poly(glycerol adipate) nanoparticles.
    Puri S; Kallinteri P; Higgins S; Hutcheon GA; Garnett MC
    J Control Release; 2008 Jan; 125(1):59-67. PubMed ID: 18035443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
    Katsikogianni G; Avgoustakis K
    J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New superamolecular polymer micelles of α-cyclodextrin and poly(l-lactide), poly (l-lactide)/poly (ε-caprolactone) copolymer.
    Du J; Dong H; Liao L; Liu L
    J Control Release; 2011 Nov; 152 Suppl 1():e17-8. PubMed ID: 22195829
    [No Abstract]   [Full Text] [Related]  

  • 58. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodegradable sirolimus-loaded poly(lactide) nanoparticles as drug delivery system for the prevention of in-stent restenosis in coronary stent application.
    Luderer F; Löbler M; Rohm HW; Gocke C; Kunna K; Köck K; Kroemer HK; Weitschies W; Schmitz KP; Sternberg K
    J Biomater Appl; 2011 May; 25(8):851-75. PubMed ID: 20237179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.